• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lab breakthrough seen in lethal dengue fever

Shiloh

Editor, Senior Moderator
Source: http://afp.google.com/article/ALeqM5i6xucs_NGqTh2DsaoZIWSOMpaZ2w

Lab breakthrough seen in lethal dengue fever

38 minutes ago

PARIS (AFP) ? Scientists in Taiwan believe they can explain how a form of dengue fever, a mosquito-borne disease that is triggering widening concern, reaps its deadly toll.

Dengue is caused by four types of virus. Infection with any one of these viruses causes a mild fever and lifelong immunity to that strain.

But a secondary infection by a different strain boosts the risk of dengue haemorrhagic fever, with internal bleeding, which can progress to the life-threatening dengue shock syndrome.

It is still unclear how this secondary infection is able to cause such serious symptoms.

One of the known factors, though, is an over-reaction by part of the immune system -- a "storm" by agents called cytokines, which run amok and cause tissue inflammation.

Reporting in Thursday's issue of Nature, researchers led by Shie-Liang Hsieh of the National Yang-Ming University in Taipei say that the cytokine storm is unleashed by interaction between the dengue virus and a molecule called CLEC5A located on immune cells.

They used antibodies on lab mice to interfere with the contact between the virus and the CLEC51. They found that this prevented inflammation but did not prevent the rest of the immune system from operating normally against infection. Fifty percent of mice treated with the antibodies were able to get rid of the virus.

The investigators admit that, so far, the experience has been limited to lab rodents, but say the discovery opens up an exciting path for exploring new therapies for humans.


Around 50 million people become infected with dengue each year, of whom around 24,000 die. About 2.5 billion people worldwide are at risk of infection.

The virus is endemic in the tropics and Africa, but scientists fear this may widen into temperate regions as global warming opens up new habitats for the Aedes aegypti (yellow fever) mosquito, the main carrier.
 
Back
Top Bottom